The usefulness of surrogate markers anti-HBc and ALT for post-transfusion non-A, non-B hepatitis prevention

Aach, 1982, Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the Transfusion Transmitted Viruses Study, N. Engl. J. Med., 304, 989, 10.1056/NEJM198104233041701

Alter, 1984, Non-A non-B hepatitis: observations on the first decade, 345

Hellings, 1986, Non-A, non-B hepatitis: an update, Vox Sang., 51, 63, 10.1111/j.1423-0410.1986.tb01998.x

Hornbrook, 1982, Reducing the incidence of non-A, non-B post transfusion hepatitis by testing donor blood for alanine aminotransferase, N. Engl. J. Med, 397, 1315, 10.1056/NEJM198211183072105

Koretz, 1985, Non-A, non-B post-transfusion hepatitis: a decade later, Gastroenterology, 88, 1251, 10.1016/S0016-5085(85)80087-1

Koziol, 1986, Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood, Ann. Intern. Med., 104, 488, 10.7326/0003-4819-104-4-488

Silverstein, 1984, Should donor blood be screened for elevated alanine aminotransferase levels? A cost effectiveness analysis, J. Am. Med. Assoc., 252, 2839, 10.1001/jama.252.20.2839

Stevens, 1984, Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the transfusion transmitted virus group, Ann. Inter. Med., 101, 733, 10.7326/0003-4819-101-6-733

Wick, 1985, Non-A, non-B hepatitis associated with blood transfusion, Transfusion, 25, 93, 10.1046/j.1537-2995.1985.25285169225.x